Doctor profile · Federal record
Dr. Sam Serafi, M.D.
Rheumatology Physician (CMS: Rheumatology) · Baltimore, MD
- NPI 1538427588
- Accepts Medicare
- MIPS 80.7 / 100 · 2023
- 14 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1220B E Joppa RD Ste 310
Baltimore, MD 212865818
(410) 494-1888
fax (410) 494-1008
Credentials & registration
- NPI registered
- April 2012 — 14 yrs on file
- Profile last updated
- September 4, 2020
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Maryland #D0083475
- Medicaid
- MD #239802800
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1538427588. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
44,396
Distinct HCPCS
10
Medicare allowed
$462,527
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 36,800 | 15 | $5 | |
J0897 |
Injection, denosumab, 1 mg | 3,902 | 45 | $23 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 690 | 344 | $96 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 441 | 60 | $1 | |
85651 |
Red blood cell sedimentation rate, to detect inflammation, non-automated | 300 | 185 | $4 | |
86140 |
Measurement c-reactive protein for detection of infection or inflammation | 287 | 179 | $5 | |
80053 |
Blood test, comprehensive group of blood chemicals | 281 | 175 | $10 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 273 | 164 | $8 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 270 | 63 | $80 | |
36415 |
Insertion of needle into vein for collection of blood sample | 263 | 150 | $8 |
In context: peer comparison
Among 15 peers in this city , average services per provider: 1,601. This provider delivers 28× the peer median.Open Payments
Industry payments received
All-time total
$458
Transactions
24
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 12 | $143.69 | |
| Amgen Inc. | 4 | $93.80 | |
| Novartis Pharmaceuticals Corporation | 3 | $65.06 | |
| Janssen Biotech, Inc. | 1 | $59.99 | |
| UCB, Inc. | 2 | $44.32 | |
| Aurinia Pharma U.S., Inc. | 1 | $29.65 | |
| PFIZER INC. | 1 | $21.26 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,005
Patients
387
Total drug cost
$654,186
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 186 | 77 | $2,447 |
| Duloxetine Hcl | Generic | 170 | 68 | $6,189 |
| Methotrexate (Methotrexate Sodium) | Brand | 137 | 54 | $7,318 |
| Hydroxychloroquine Sulfate | Generic | 102 | 43 | $6,942 |
| Tramadol Hcl | Generic | 71 | 22 | $181 |
| Gabapentin | Generic | 53 | 22 | $1,425 |
| Allopurinol | Generic | 46 | 17 | $763 |
| Enbrel Sureclick (Etanercept) | Brand | 41 | 0 | $298,696 |
| Alendronate Sodium | Generic | 39 | 16 | $450 |
| Leflunomide | Generic | 35 | 17 | $2,851 |
Frequently asked questions
What is Dr. Sam Serafi's medical specialty?
Dr. Sam Serafi practices Rheumatology Physician in Baltimore, MD.
Where does Dr. Sam Serafi practice?
Dr. Sam Serafi practices at 1220B E Joppa RD Ste 310, Baltimore, MD 212865818. Office phone: 4104941888.
What is Dr. Sam Serafi's NPI?
Dr. Sam Serafi's National Provider Identifier (NPI) is 1538427588, issued by NPPES.
Does Dr. Sam Serafi accept Medicare assignment?
Yes. Dr. Sam Serafi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sam Serafi commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.